|
[1]
|
Schachinger, V., Erbs, S., Elsasser, A., et al. (2006) Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial. European Heart Journal, 27, 2775-2783.
doi:10.1093/eurheartj/ehl388
|
|
[2]
|
Schachinger, V., Erbs, S., Elsasser, A., et al. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine, 355, 1210-1221. doi:10.1056/NEJMoa060186
|
|
[3]
|
Lunde, K., Solheim, S., Aakhus, S., et al. (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. The New England Journal of Medicine, 355, 1199-1209. doi:10.1056/NEJMoa055706
|
|
[4]
|
Janssens, S., Dubois, C., Bogaert, J., et al. (2006) Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet, 367, 113- 121.
doi:10.1016/S0140-6736(05)67861-0
|
|
[5]
|
Chen, S.L., Fang, W.W., Ye, F., et al. (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. American Journal of Cardiology, 94, 92-95.
doi:10.1016/j.amjcard.2004.03.034
|
|
[6]
|
Lipinski, M.J., Biondi-Zoccai, G.G., Abbate, A., et al. (2007) Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. Journal of the American College of Cardiology, 50, 1761-1767.
doi:10.1016/j.jacc.2007.07.041
|
|
[7]
|
Lunde, K., Solheim, S., Forfang, K., et al. (2008) Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: Safety, clinical outcome, and serial changes in left ventricular function during 12-months’ follow-up. Journal of the American College of Cardiology, 51, 674-676.
doi:10.1016/j.jacc.2007.10.032
|
|
[8]
|
Meyer, G.P., Wollert, K.C., Lotz, J., et al. (2006) Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 113, 1287-1294.
doi:10.1161/CIRCULATIONAHA.105.575118
|
|
[9]
|
Yousef, M., Schannwell, C.M., Kostering, M., et al. (2009) The BALANCE Study: Clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. Journal of the American College of Cardiology, 53, 2262-2269. doi:10.1016/j.jacc.2009.02.051
|
|
[10]
|
Hale, S.L., Dai, W., Dow, J.S., et al. (2008) Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: A quantitative assessment. Life Sciences, 83, 511-515. doi:10.1016/j.lfs.2008.07.020
|
|
[11]
|
Li, Z., Lee, A., Huang, M., et al. (2009) Imaging survival and function of transplanted cardiac resident stem cells. Journal of the American College of Cardiology, 53, 1229- 1240. doi:10.1016/j.jacc.2008.12.036
|
|
[12]
|
Forrester, J.S. and Libby, P. (2007) The inflammation hypothesis and its potential relevance to statin therapy. American Journal of Cardiology, 99, 732-738.
doi:10.1016/j.amjcard.2006.09.125
|
|
[13]
|
Cook, S.A., Matsui, T., Li, L., et al. (2002) Transcriptional effects of chronic Akt activation in the heart. Journal of Biological Chemistry, 277, 22528-22533.
doi:10.1074/jbc.M201462200
|
|
[14]
|
Klopsch, C., Furlani, D., Gabel, R., et al. (2009) Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. Journal of Cellular and Molecular Medicine, 13, 664-679.
doi:10.1111/j.1582-4934.2008.00546.x
|
|
[15]
|
Hahn, J.Y., Cho, H.J., Kang, H.J., et al. (2008) Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. Journal of the American College of Cardiology, 51, 933-943.
doi:10.1016/j.jacc.2007.11.040
|
|
[16]
|
Laflamme, M.A., Chen, K.Y., Naumova, A.V., et al. (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25, 1015-1024.
doi:10.1038/nbt1327
|
|
[17]
|
Pasha, Z., Wang, Y., Sheikh, R., et al. (2008) Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovascular Research, 77, 134-142.
doi:10.1093/cvr/cvm025
|
|
[18]
|
Hu, X., Yu, S.P., Fraser, J.L., et al. (2008) Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. Journal of Thoracic and Cardiovascular Surgery, 135, 799-808.
doi:10.1016/j.jtcvs.2007.07.071
|
|
[19]
|
Bartunek, J., Croissant, J.D., Wijns, W., et al. (2007) Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. American Journal of Physiology—Heart and Circulatory Physiology, 292, H1095-H1104. doi:10.1152/ajpheart.01009.2005
|
|
[20]
|
Gnecchi, M., He, H., Melo, L.G., et al. (2009) Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells, 27, 971-979.
doi:10.1002/stem.12
|
|
[21]
|
Haider, H., Jiang, S., Idris, N.M., et al. (2008) IGF-1- overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circulation Research, 103, 1300-1308.
doi:10.1161/CIRCRESAHA.108.186742
|
|
[22]
|
Li, W., Ma, N., Ong, L.L., et al. (2007) Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells, 25, 2118-2127.
doi:10.1634/stemcells.2006-0771
|
|
[23]
|
Simpson, D., Liu, H., Fan, T.H., et al. (2007) A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells, 25, 2350-2357.
doi:10.1634/stemcells.2007-0132
|
|
[24]
|
Takehara, N., Tsutsumi, Y., Tateishi, K., et al. (2008) Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. Journal of the American College of Cardiology, 52, 1858- 1865. doi:10.1016/j.jacc.2008.06.052
|
|
[25]
|
Davis, M.E., Hsieh, P.C., Takahashi, T., et al. (2006) Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proceedings of the National Academy of Sciences USA, 103, 8155-8160.
doi:10.1073/pnas.0602877103
|
|
[26]
|
Padin-Iruegas, M.E., Misao, Y., Davis, M.E., et al. (2009) Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation, 120, 876-887.
doi:10.1161/CIRCULATIONAHA.109.852285
|
|
[27]
|
Wang, F., Li, Z., Tamama, K., et al. (2009) Fabrication and characterization of prosurvival growth factor releasing, anisotropic scaffolds for enhanced mesenchymal stem cell survival/growth and orientation. Biomacromolecules, 10, 2609-2618. doi:10.1021/bm900541u
|
|
[28]
|
Shim, W.S., Jiang, S., Wong, P., et al. (2004) Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochemical and Biophy- sical Research Communications, 324, 481-488.
doi:10.1016/j.bbrc.2004.09.087
|
|
[29]
|
Laflamme, M.A. and Murry, C.E. (2005) Regenerating the heart. Nature Biotechnology, 23, 845-856.
doi:10.1038/nbt1117
|
|
[30]
|
Scorsin, M., Hagege, A.A., Marotte, F., et al. (1997) Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation, 96, II188-II193.
|
|
[31]
|
Smith, R.R., Barile, L., Cho, H.C., et al. (2007) Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation, 115, 896-908.
doi:10.1161/CIRCULATIONAHA.106.655209
|
|
[32]
|
Oh, H., Bradfute, S.B., Gallardo, T.D., et al. (2003) Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proceedings of the National Academy of Sciences USA, 100, 12313- 12318. doi:10.1073/pnas.2132126100
|
|
[33]
|
Ott, H.C., Matthiesen, T.S., Brechtken, J., et al. (2007) The adult human heart as a source for stem cells: Repair strategies with embryonic-like progenitor cells. Nature Clinical Practice Cardiovascular Medicine, 4, S27-S39.
doi:10.1038/ncpcardio0771
|
|
[34]
|
Beltrami, A.P., Barlucchi, L., Torella, D., et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114, 763-776.
doi:10.1016/S0092-8674(03)00687-1
|
|
[35]
|
Tang, X.L., Rokosh, G., Sanganalmath, S.K., et al. (2010) Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30- day-old infarction. Circulation, 121, 293-305.
doi:10.1161/CIRCULATIONAHA.109.871905
|
|
[36]
|
Rota, M., Padin-Iruegas, M.E., Misao, Y., et al. (2008) Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circulation Research, 103, 107-116.
doi:10.1161/CIRCRESAHA.108.178525
|
|
[37]
|
Dawn, B., Stein, A.B., Urbanek, K., et al. (2005) Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proceedings of the National Academy of Sciences USA, 102, 3766-3771.
doi:10.1073/pnas.0405957102
|
|
[38]
|
Makkar, R.R., Smith, R.R., Cheng, K., et al. (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial. Lancet, 13, 13.
|
|
[39]
|
Kehat, I., Kenyagin-Karsenti, D., Snir, M., et al. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. Journal of Clinical Investigation, 108, 407- 414.
|
|
[40]
|
Rufaihah, A.J., Haider, H.K., Heng, B.C., et al. (2010) Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair. Regenerative Medicine, 5, 231-244. doi:10.2217/rme.09.83
|
|
[41]
|
Nelson, T.J., Martinez-Fernandez, A., Yamada, S., et al. (2009) Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation, 120, 408-416.
doi:10.1161/CIRCULATIONAHA.109.865154
|
|
[42]
|
Yu, J., Vodyanik, M.A., Smuga-Otto, K., et al. (2007) In- duced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-1920.
doi:10.1126/science.1151526
|
|
[43]
|
Behfar, A., Crespo-Diaz, R., Nelson, T.J., et al. (2010) Stem cells: Clinical trials results the end of the beginning or the beginning of the end? Cardiovascular & Hematological Disorders Drug Targets, 10, 186-201.
|
|
[44]
|
Strauer, B.E., Brehm, M., Zeus, T., et al. (2002) Repair of infarcted myocardium by autologous intracoronary mono-nuclear bone marrow cell transplantation in humans. Circulation, 106, 1913-1918.
doi:10.1161/01.CIR.0000034046.87607.1C
|
|
[45]
|
Bartunek, J., Vanderheyden, M., Vandekerckhove, B., et al. (2005) Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: Feasibility and safety. Circulation, 112, I178-1183.
|
|
[46]
|
Li, Z.Q., Zhang, M., Jing, Y.Z., et al. (2007) The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). International Journal of Cardiology, 115, 52-56. doi:10.1016/j.ijcard.2006.04.005
|
|
[47]
|
Kang, H.J., Lee, H.Y., Na, S.H., et al. (2006) Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: The MAGIC Cell-3-DES randomized, controlled trial. Circulation, 114, I145-I151.
doi:10.1161/CIRCULATIONAHA.105.001107
|
|
[48]
|
Ge, J., Li, Y., Qian, J., et al. (2006) Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart, 92, 1764-1767. doi:10.1136/hrt.2005.085431
|
|
[49]
|
Meluzin, J., Mayer, J., Groch, L., et al. (2006) Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial function. American Heart Journal, 152, 975e9-975e15.
|
|
[50]
|
Makkar, R.R., Price, M.J., Lill, M., et al. (2005) Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. Journal of Cardiovascular Pharmacology and Therapeutics, 10, 225-233.
doi:10.1177/107424840501000403
|